Cigna's Impressive Q3: 4 Compelling Reasons To Buy Now
The Cigna Group's Q3 2024 results showed once again strong revenue and earnings growth. Yet, CI shares are down almost 20% from their 52-week-high. In this article, I will discuss the reasons for the once again favorable valuation of CI stock and explain why I seized what I believe to be a compelling opportunity. I will also give my opinion on the renewed speculation about a possible merger with Humana and explain why the concerns are likely unfounded.
Here's Why Cigna (CI) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cigna (CI) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The Cigna Group (CI) Q3 2024 Earnings Call Transcript
The Cigna Group (NYSE:CI ) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Ralph Giacobbe - Senior Vice President of Investor Relations David Cordani - Chairman and Chief Executive Officer Brian Evanko - Chief Financial Officer and President and Chief Executive Officer, Cigna Healthcare Eric Palmer - President and Chief Executive Officer, Evernorth Health Services Conference Call Participants AJ Rice - UBS Justin Lake - Wolfe Research Ryan Langston - TD Cowen Lisa Gill - JPMorgan Andrew Mok - Barclays Erin Wright - Morgan Stanley Scott Fidel - Stephens Adam Ron - Bank of America George Hill - Deutsche Bank Josh Raskin - Nephron Research Lance Wilkes - Bernstein Michael Ha - Baird Operator Ladies and gentlemen, thank you for standing by for the Cigna Group's Third Quarter 2024 Results Review. At this time all callers are in a listen-only mode.
Cigna Q3 Earnings Beat on Client Wins & Specialty Business Strength
CI's strong third-quarter results benefit from a strong Evernorth Health Services segment. Higher expenses partially offset the positives.
Cigna (CI) Surpasses Q3 Earnings and Revenue Estimates
Cigna (CI) came out with quarterly earnings of $7.51 per share, beating the Zacks Consensus Estimate of $7.22 per share. This compares to earnings of $6.77 per share a year ago.
Cigna tops quarterly profit estimates on strength in pharmacy benefit management unit
Cigna beat Wall Street estimates for third-quarter profit on Thursday, as its unit that runs the pharmacy benefit management business added new clients and saw strong demand for close copies of a blockbuster arthritis drug.
Cigna Turns $739 Million Profit Despite $1 Billion Loss On VillageMD
The Cigna Group reported a $739 million third quarter profit despite a $1 billion loss on its investment in clinic operator VillageMD.
Cigna Earnings Are Soon. It's Been a Bumpy Season for Managed Care Stocks.
Analysts expect the company to report earnings of $7.23 per share for the third quarter and sales of $59.6 billion.
Cigna Considers Humana Acquisition – What It Means for the Stocks
There has been speculation of a massive merger in the medical sector between two massive health insurers. Specifically, the rumor is The Cigna Group NYSE: CI is interested in acquiring Humana Inc. NYSE: HUM.
Countdown to Cigna (CI) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Cigna (CI) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Why Cigna Group Stock Got Mashed on Monday
A media report stated that the company is determined to grow with a major merger deal.
